FEG Holdings (1413) announced on January 12 that it signed a non-binding strategic cooperation framework agreement with Sichuan Kuaike Automotive Service Co., Ltd. on December 30, 2025, to jointly develop the online ride-hailing and new energy mobility market in Greater China. Cooperation areas include market expansion, new energy vehicle operations, and charging/swapping network construction. The core management team comprises Sun Shifeng, Zhu Xunqing, Ji Xiaofeng, and Meng Junjun. The Board views the partnership as aligning with its growth strategy but emphasized that the agreement is only preliminary, with no binding terms for specific projects, uncertain prospects for advancement, and does not constitute a notifiable transaction under listing rules.
Softcare (2698) announced on January 12 that, due to changes in key personnel at Dongwu Securities International Financing Limited, both parties have agreed to terminate the compliance adviser agreement effective January 12, 2026, and concurrently appointed China Ping An Capital (Hong Kong) Limited, where the former Dongwu personnel now work, as the new compliance adviser. The appointment runs until either the compliance date for 2026 financial results or termination under the agreement, whichever is earlier. Both the Board and Dongwu Securities confirmed no other matters require shareholders' or the Stock Exchange's attention.
Dongfeng Motor Group's 2025 full-year sales reached 1.896 million units, up 0.01% YoY, with new energy vehicle sales of 563,000 units (+42.6% YoY) emerging as the key growth driver. Voyah sales grew 87.4% and M-Hero jumped nearly five-fold, while the three major joint venture brands—Dongfeng Nissan, Dongfeng Honda, and DPCA—all posted declines. Heavy-duty truck segment performed strongly, rising 25.3% YoY to 181,000 units. The company cautioned that data remains unaudited and unconfirmed by auditors.
SHENZHENEXPRESS and its controlling shareholder SHENZHEN INT'L jointly announced that they have subscribed to structured deposits from Bank of Jiangsu in two installments on January 9 and 12. Each installment has a principal of RMB500 million, totaling RMB1 billion. Both products are principal-guaranteed floating-income type with a term of 66 days and a yield rate range of 1.2%-3.3%.
WuXi AppTec (02359.HK) has issued a positive profit warning, projecting that its net profit attributable to shareholders for the 2025 fiscal year will surge by approximately 102.65% year-on-year to around RMB 19.15 billion. This growth is mainly driven by the steady expansion of its core CRDMO business and non-recurring investment gains. Meanwhile, the company’s operating revenue is expected to climb by about 15.84% year-on-year to roughly RMB 45.46 billion.
CYBERNAUT INT’L announced that to align with the company's development needs and enhance corporate governance standards, Executive Director Kong Junmin has been appointed as Chief Executive Officer (CEO), effective January 12, 2026.
SAMPLE TECH announced that it has confirmed Nanjing Institute of Metrology Supervision and Inspection as the transferee of the assets through a public listing process. A transaction agreement was signed on January 8, 2026, specifying the transfer of relevant assets at a consideration of RMB187 million (including value-added tax). The transaction has obtained shareholder and regulatory approvals and is expected to be completed by the end of the first half of 2026.
XIAOMI-W(01810.HK) will spend HKD 151.33 million to repurchase 4 million shares on Jan 9, 2026 .
GIANT BIOGENE(02367.HK) will spend HKD 13.76 million to repurchase 400 thousand shares on Jan 9, 2026 .
DMALL(02586.HK) will spend HKD 5.52 million to repurchase 703 thousand shares on Jan 9, 2026 .
GEELY AUTO(00175.HK) will spend HKD 26.62 million to repurchase 1.55 million shares on Jan 9, 2026 .
TENCENT(00700.HK) will spend HKD 635.93 million to repurchase 1.04 million shares on Jan 9, 2026 .
SUNNY OPTICAL(02382.HK) will spend HKD 53.99 million to repurchase 840 thousand shares on Jan 9, 2026 .
STANCHART(02888.HK) will spend GBP 9.97 million to repurchase 552.73 thousand shares on Jan 8, 2026 .
Peking University Resources (Holdings) Company Limited (00618.HK) announced that ResoHealth, the Group’s Dubai-based healthcare business unit, has partnered with Trivitron Healthcare to launch the Trivitron Digital AI Digital Health Initiative in India. The platform aims to enhance the operational efficiency of hospitals and the patient diagnosis and treatment experience in India’s tier-2 and tier-3 cities through cloud solutions and AI technologies, with future plans to expand into the African, Middle Eastern and Southeast Asian markets.
MIRXES-B (02629.HK) announced that it has established a strategic cooperation with N Health, an affiliate of BDMS (Bangkok Dusit Medical Services (BDMS) Group)—Thailand’s largest healthcare provider—to jointly promote miRNA cancer screening solutions in Thailand. In addition, two of the Company’s at-home test kits (Helicobacter pylori and fecal occult blood tests) have obtained approval from Thailand’s FDA and are officially launched on January 9, 2026.
